Eylea outperforms other drugs for diabetic macular edema with moderate or worse vision loss
Lucentis and Avastin perform similarly to Eylea when vision loss is mild, NIH study shows.
Source: National Institutes of Health (NIH) News Releases - Category: American Health Source Type: news
More News: American Health | Avastin | Diabetes | Endocrinology | Eyes | Health | Lucentis | National Institutes of Health (NIH) | Ranibizumab Injection | Study